Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics



Quinn, Tom M, Gaughan, Erin E, Bruce, Annya, Antonelli, Jean, O'Connor, Richard, Li, Feng, McNamara, Sarah, Koch, Oliver, MacKintosh, Claire, Dockrell, David
et al (show 39 more authors) (2022) Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics. EBIOMEDICINE, 76.

Access the full-text of this item by clicking on the Open Access link.
Item Type: Article
Uncontrolled Keywords: Respiratory medicine, Infectious diseases, SARS-CoV-2/COVID-19, Nafamostat mesylate, Total manuscript word count
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology
Faculty of Science and Engineering > School of Physical Sciences
Depositing User: Symplectic Admin
Date Deposited: 06 Apr 2022 13:11
Last Modified: 11 Aug 2022 03:10
DOI: 10.1016/j.ebiom.2022.103856
Open Access URL: https://www.thelancet.com/journals/ebiom/article/P...
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3152276